FDMT EBITDA Margin
4D Molecular Therapeutics Inc · EBITDA Margin
FDMT EBITDA Margin
Latest reported-199.94%period ending
FDMT TTM EBITDA Margin (-68.66% → -199.94%)
TTM ebitda margin
High-resolution chart · PNG
FDMT ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -199.9413% | |
| -183.543% | |
| -166.0329% | |
| -168,123.3333% | |
| -572,772.7273% | |
| -737,278.2609% | |
| -416,656.7568% | |
| -806,152.9412% | |
| -513.2357% | |
| -482.2267% | |
| -458.8746% | |
| -410.7195% | |
| -4,652.4081% | |
| -4,772.4513% | |
| -3,312.468% | |
| -5,094.1206% | |
| -3,422.8249% | |
| -444.8398% | |
| -372.2198% | |
| -378.9734% | |
| -218.3634% | |
| -482.0651% | |
| -405.6788% | |
| -307.7201% | |
| -567.8681% | |
| -589.8292% | |
| -638.7489% | |
| -326.8434% | |
| -161.4083% | |
| -113.9385% | |
| -68.6624% |